Evidence map›Paper›PMID 40281269›Full record

ArticleFolia microbiologica2026

The response surface method enables efficient optimization of induction parameters for the production of bioactive peptides in fed-batch bioreactors using Escherichia coli.

Z R Khasanshina, I A Kornakov, E A Buslaeva, R V Drai

Abstract read
PubMed Publisher
In one paragraph

Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Z R KhasanshinaPharm-Holding (RnD GEROPHARM), St. Petersburg, P. Strelna 34-A Svyazi Street, 198515, Russia. hasanshinazuhrar@gmail.com.ORCID http://orcid.org/0000-0002-0065-1853
I A KornakovPharm-Holding (RnD GEROPHARM), St. Petersburg, P. Strelna 34-A Svyazi Street, 198515, Russia.
E A BuslaevaPharm-Holding (RnD GEROPHARM), St. Petersburg, P. Strelna 34-A Svyazi Street, 198515, Russia.
R V DraiPharm-Holding (RnD GEROPHARM), St. Petersburg, P. Strelna 34-A Svyazi Street, 198515, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The production of recombinant peptides is critical in biotechnology and medicine for treating a variety of diseases. Thus, there is an urgent need for the development of quick, scalable, and cost-effective recombinant protein expression strategies. This study optimizes induction conditions for an insulin precursor, an analog GLP-1 precursor, and a peptide for COVID-19 therapy expression in E. coli using the response surface method. Factors such as pH, temperature, induction time, isopropyl-β-D-thiogalactopyranoside concentration, and optical density significantly influence peptide productivity. Experimental validation supports the effectiveness of these models in predicting peptide yields under optimal conditions. The optimal induction conditions were determined as follows: temperature at 37 °C, pH of the medium 7.0-8.0, induction at the early logarithmic phase of growth, isopropyl-β-D-thiogalactopyranoside concentration of 0.05 mM, and induction time of 6 h. After model validation, the productivity of each peptide producer exceeded 3 g/L. The optimal conditions achieved peptide titers significantly higher than those previously reported, suggesting that this technique is a versatile cultivation technology for the efficient production of different recombinant peptides. In conclusion, our research enhances the understanding of how tailored cultivation conditions can optimize recombinant peptide production efficiency.

Indexed as

Batch Cell Culture TechniquesBioreactorsEscherichia coliPeptidesCulture MediaGlucagon-Like Peptide 1Hydrogen-Ion ConcentrationIsopropyl ThiogalactosideRecombinant ProteinsTemperatureCulture MediaGlucagon-Like Peptide 1Isopropyl ThiogalactosidePeptidesRecombinant ProteinsGLP- 1Inclusion bodyInsulinRecombinant peptideResponse surface methodSoluble protein expression

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.